Michele Clark, Author at Chembio Diagnostics, Inc.

Uncategorized

FDA AWARDS BREAKTHROUGH DEVICE STATUS TO THE DPP® SYPHILIS TnT ASSAY

Chembio

FDA Awards Breakthrough Device Status to the SURE CHECK® HIV Self-Test

Chembio

Chembio Diagnostics Inc. receives a grant for Development of a DPP Congenital Syphilis Assay

Chembio

Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

Chembio

Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System

Chembio

Chembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial Channel

Chembio

Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors

COVID-19 Nasal Swab Test Image

Chembio

Chembio Announces EUA Submission for DPP Respiratory Antigen Panel: Test Provides Simultaneous Detection of Flu A, Flu B, and SARS-CoV-2

Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay

Chembio

Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay

Chembio

Watch the recorded Webinar, Fighting the Syphilis & HIV Epidemics: Voices from the Field

© 2025 Chembio Diagnostics, Inc.. Privacy Policy | Terms & Conditions